Table 3. Clinical outcomes.
| Variable | All patients | Propensity-matched patients | |||||
|---|---|---|---|---|---|---|---|
| MIDCAB-first (n=286) | PCI-first (n=109) | P value | MIDCAB-first (n=109) | PCI-first (n=109) | P value | ||
| Short-term outcomes | |||||||
| 30-day mortality | 1 (0.3) | 0 | >0.999 | 0 | 0 | >0.999 | |
| Stroke | 0 | 1 (0.9) | >0.999 | 0 | 1 (0.9) | >0.999 | |
| Postoperative chest tube output, mL | 648.48±812.70 | 494.89±371.12 | 0.223 | 693.21±999.73 | 494.89±371.12 | 0.209 | |
| Transfusion required | 19 (6.6) | 11 (10.1) | 0.288 | 8 (7.3) | 11 (10.1) | 0.632 | |
| Reoperation for bleeding | 10 (3.5) | 6 (5.5) | 0.395 | 2 (1.8) | 6 (5.5) | 0.280 | |
| Perioperative myocardial infarction | 0 | 0 | >0.999 | 0 | 0 | >0.999 | |
| New dialysis-dependent renal failure | 1 (0.3) | 1 (0.9) | >0.999 | 1 (0.9) | 1 (0.9) | >0.999 | |
| Postoperative length of stay, days | 5.25±6.23 | 5.21±3.86 | 0.949 | 5.15±3.08 | 5.21±3.86 | 0.892 | |
| Postoperative length of stay, days | 4 (3 to 6) | 4 (3 to 5) | – | 5 (4 to 6) | 4 (3 to 5) | – | |
| Mid to longer-term outcomes | |||||||
| Mortality | 17 (5.9) | 8 (7.3) | 0.781 | 0 | 8 (7.3) | 0.567 | |
| Stroke | 2 (0.7) | 2 (1.8) | 0.656 | 1 (0.9) | 2 (1.8) | >0.999 | |
| Myocardial infarction | 4 (1.4) | 1 (0.9) | >0.999 | 0 | 1 (0.9) | >0.999 | |
| Repeat revascularization procedure | 41 (14.3) | 16 (14.7) | >0.999 | 14 (12.8) | 16 (14.7) | 0.844 | |
| MACCE | 57 (19.9) | 22 (20.2) | >0.999 | 19 (17.4) | 22 (20.2) | 0.729 | |
Values are expressed as n (%), mean ± standard deviation, or median (IQR). MIDCAB, minimally-invasive direct coronary artery bypass; PCI, percutaneous coronary intervention; MACCE, major adverse cardiovascular and cerebrovascular event; IQR, interquartile range.